Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Singapore Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20042
20053
20061
20075
20085
20093
20104
20117
20125
20132
20142
20154
20162
20177
20185
201910
20207
20215
20225
20239
20245
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Unknown status15
Terminated10
Recruiting8
Active, not recruiting5
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company17
Singapore General Hospital15
National University of Singapore8
Novo Nordisk A/S8
Singapore Institute of Food and Biotechnology Innovation8
AstraZeneca6
Novartis Pharmaceuticals6
Bayer4
SingHealth Polyclinics4
Changi General Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2109
Diabetes Mellitus28
Obesity12
Hypertension8
Cardiovascular Diseases4
Glucose Intolerance4
Diabetic Nephropathies3
Hyperglycemia3
Insulin Resistance3
Kidney Diseases3

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.